David S. Wang, MD

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

David S. Wang, M.D., is an Associate Professor of Urology at the Chobanian and Avedisian School of Medicine. Dr. Wang is an expert in the field of endoscopic and minimally invasive urologic surgery.

Dr. Wang completed his residency training in General Surgery at the Massachusetts General Hospital/Harvard Medical School and in Urology at the Lahey Clinic Medical Center. He then completed a Fellowship in Endourology and Laparoscopic Surgery at the University of Iowa.

He has published extensively in leading urology journals and has presented at conferences at the national and international level. Dr. Wang has considerable experience in laparoscopic surgery, including robotic radical prostatectomy, radical nephrectomy, donor nephrectomy, partial nephrectomy, and repair of ureteropelvic junction obstruction. He has incorporated the daVinci robot into his practice to enhance his surgical repertoire.

Dr. Wang is also proficient in endoscopic surgery for both benign and malignant conditions, including urinary tract stones and tumors. He has extensive experience in percutaneous kidney stone removal, ureteroscopy (endoscopy of the ureter), and also shock-wave lithotripsy.

Dr. Wang is board-certified by the American Board of Urology and is a Fellow of the Endourological Society. He is also a member of the American Urological Association

Publications

  • Published 9/26/2025

    Lu Z, Zhou Y, Fan W, Choksi S, Sultan L, Katz MH, Wang DS, Zhao Q, Yang S. Biphasic (squamoid) papillary renal cell carcinoma: a distinct molecular and morphologic subtype within the PRCC spectrum. Virchows Arch. 2025 Sep 26. PMID: 41006900.

    Read at: PubMed

  • Published 9/17/2025

    Zewdu A, Braggio D, Lopez G, Batte K, Khurshid S, Costas C de Faria F, Bid HK, Koller D, Casadei L, Ladner KJ, Wang D, Grignol V, Iwenofu OH, Chandler D, Guttridge DC, Pollock RE. Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicing. PLoS One. 2025; 20(9):e0299962. PMID: 40961077.

    Read at: PubMed

  • Published 9/17/2025

    Wechsler PM, Sucharew H, Robinson DJ, Stanton RJ, Aziz YN, Prestigiacomo C, Demel SL, Horn P, Maloney TC, Williamson BJ, Wang L, Khandwala VJ, Gangatirkar S, Gaskill-Shipley M, Haverbusch M, Tomsick T, Wang D, Cornelius RS, Woo D, Broderick JP, Kleindorfer DO, Kissela BM, Flaherty ML, Mistry EA, Vagal A, Khatri P. Projecting US Population Eligibility for Minimally Invasive Surgical Evacuation of Intracerebral Hemorrhage. Stroke. 2025 Sep 17. PMID: 40959870.

    Read at: PubMed

  • Published 9/3/2025

    Johnson T, Spieler BO, Toskich BB, Wang DS, Folkert MR, Russo S, Sharma NK, Kim CY, Wright CL, Kappadath SC, Farsad K, Muzahir S, Chundury A, Parent EE, Sio TT, Mercier GA, Ghesani MV, Subramaniam RM, Caplin D, Small W, Schechter NR. ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies. Am J Clin Oncol. 2025 Sep 03. PMID: 40899409.

    Read at: PubMed

  • Published 8/26/2025

    de Araújo Castro Í, Terada Y, Yokoyama Y, Bery AI, Li W, Amrute JM, Liu CR, Bai YZ, Gnazzo V, Turnquist HR, Lavine KJ, Krupnick AS, Gelman AE, Ritter JH, Blatter JA, Wang D, López CB, Kreisel D. Tolerogenic lung allograft microenvironment suppresses pathogenic tissue remodeling following respiratory virus infection in mice. Am J Transplant. 2025 Aug 26. PMID: 40865875.

    Read at: PubMed

View All 275 Publications:   View Full Profile in BUMC

Websites

Education

  • Yale University, MD
  • Northwestern University, BA

View all profiles